Kit for detecting urothelial carcinoma by identifying UMOD-modified Neu5Gc in urine based on LIP
A technology of urothelial carcinoma and kit, applied in the field of biomedical detection, to achieve the effect of good clinical specimen detection ability, high sensitivity and specificity, and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0045] Adopt the present invention to implement 639 cases of normal people, 25 cases of benign diseases (8 cases of bladder inflammation, 7 cases of bladder cyst, 6 cases of bladder polyps, 4 cases of nephritis), 99 cases of urothelial cancer patients (52 cases of bladder cancer, 20 cases of renal cancer and 27 cases of prostate cancer) urine test samples were tested and the results were as follows figure 1 shown. figure 1 It showed that the Neu5Gc content of LIP-specific recognition modified UMOD glycoprotein in normal human urine samples was 67.63±9.31 ng / mg; the Neu5Gc content of LIP-specific recognition modified UMOD glycoprotein in 25 cases of benign disease urine samples was not significantly higher than that of normal people. Sexual differences, ranging from 70.71±8.20 ng / mg. The results showed that: in the screening of urinary tract cancer, when there are benign problems such as inflammation in the urinary tract, there is no difference between the content of Neu5Gc th...
PUM
Property | Measurement | Unit |
---|---|---|
Concentration | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com